Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 USD | +2.98% | -2.38% | +7.89% |
04-04 | UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating | MT |
04-01 | Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating | MT |
Evolution of the average Target Price on Kodiak Sciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kodiak Sciences Inc.
UBS | |
Barclays | |
JPMorgan Chase | |
Chardan Research | |
Capital One Securities | |
Morgan Stanley | |
Goldman Sachs | |
Truist Securities | |
Citigroup | |
Berenberg Bank | |
BMO Capital | |
J.P. Morgan Chase | |
Roth Capital Partners | |
Evercore ISI |
EPS Revisions
- Stock Market
- Equities
- KOD Stock
- Consensus Kodiak Sciences Inc.